NIH-funded research R01 grant

How low GAS7 levels and high MYCN levels affect neuroblastoma spread

Official title: Interplay between low levels of GAS7 expression and MYCN overexpression and its impact on neuroblastoma metastasis

Funded at Mayo Clinic Rochester · NIH-10877719 · Data updated 2026-11-12

This study is looking at how two specific genes are connected in neuroblastoma, a type of cancer that affects kids, to find new ways to help treat children with this illness better and more safely.

More Metastasis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startJuly 15, 2020
Project endJune 30, 2026
Funding year2024
Award (this year)$345,528
NIH project number5R01CA240323-05
Project IDNIH-10877719 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children diagnosed with neuroblastoma, particularly those with MYCN amplification and advanced-stage disease.

Less likely to help

Patients with neuroblastoma who do not have MYCN amplification or those with early-stage disease may not benefit from this research.

What this research studies

This research investigates the relationship between low levels of the GAS7 gene and high levels of the MYCN oncogene in neuroblastoma, a common childhood cancer. By analyzing genetic data from patients and using zebrafish models, the study aims to understand how these genetic factors contribute to the spread of neuroblastoma. The goal is to uncover new mechanisms that could lead to safer and more effective treatments for children with advanced neuroblastoma. Patients may benefit from insights that could improve treatment strategies and outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options and outcomes for children with high-risk neuroblastoma.

How similar studies have gone: Previous research has shown promising results in understanding the genetic factors influencing neuroblastoma, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Zhu, Shizhen — Mayo Clinic Rochester
  • Study coordinator: Zhu, Shizhen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.